Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalpiciclib + Entinostat + Letrozole vs Dalpiciclib + Letrozole in HR+/HER2- Early Breast Cancer
NCT07492394Phase 2Recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in breast cancer, sponsored by The Fourth Hospital of Hebei Medical University. Started Sep 2025; status: recruiting.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07492394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07492394.